Actively Recruiting

Age: 18Years +
All Genders
ID06935448

Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy; Experience From Two Referral Centers in Central Greece.

Led by University of Thessaly · Updated on 2025-04-20

170

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether patients with pancreatic cancer who undergo surgery have better outcomes when cared for using a multidisciplinary approach called an enhanced recovery after surgery (ERAS) program. This study compares patients treated before and after the program's implementation to understand its effect on recovery and health after surgery. Patients having elective pancreatic surgery are managed either with traditional perioperative care or following a standardized ERAS protocol involving 20 different care elements before, during, and after surgery. The study includes two groups: a control group treated with standard care and an ERAS group receiving the enhanced recovery program, both observed at two high-volume referral centers. Participants are followed to assess their length of hospital stay within 30 days after surgery, along with monitoring 30-day mortality and overall complications. Data are collected prospectively for the ERAS group and retrospectively for the control group. The study aims to measure how these care approaches impact recovery and short-term outcomes after pancreas surgery.

CONDITIONS

Brief Title

Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients
  • Diagnosis of pancreatic cancer
  • Elective open pancreatic surgery
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Emergency pancreatic surgery
  • Other surgical procedures
  • Missing data
  • Lost to follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Hospital stay period after surgery

Participants undergo elective open pancreatic surgery and receive either traditional perioperative care or enhanced recovery after surgery (ERAS) care.

Hospital stay with daily assessments until discharge

Post-operative Follow-up

Duration - Up to 30 days after surgery

Participants are monitored for recovery, complications, and outcomes including length of hospital stay, morbidity, and mortality within 30 days after surgery.

Follow-up visits as needed within 30 days post-surgery

Trial Site Locations

Total: 1 location

1

University of Thessaly

Larissa, Greece

Actively Recruiting

Loading map...

Research Team

D

DESPOINA LIOTIRI, MD MSc PhD(c)

A

ATHINA SAMARA, MD MSc PhD(c)

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A New Clinical Pathway for Personalized Management of Border...

Locally Advanced Pancreatic Cancer

Actively Recruiting

5 locations

Antecolic Versus Retrocolic Gastrojejunostomy Following Panc...

Pancreatic Cancer Resectable

Actively Recruiting

1 location

Clinical Study of XP-004 Personalized mRNA Vaccine Combined ...

Pancreatic Cancer Resectable

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial